Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on Trevor Young’s Substack. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc.'s share was trading at $135.87 as of April 20th. GILD’s trailing and forward P/E were 20.04 and 15.50 respectively according to Yahoo Finance.
[caption id="attachment_522188" align="aligncenter" width="750"]Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.